124 related articles for article (PubMed ID: 15865730)
1. Schizophrenia.
McIntosh A; Lawrie S
Clin Evid; 2004 Dec; (12):1502-33. PubMed ID: 15865730
[No Abstract] [Full Text] [Related]
2. Schizophrenia.
Nadeem Z; McIntosh A; Lawrie S
Clin Evid; 2003 Dec; (10):1208-37. PubMed ID: 15555143
[No Abstract] [Full Text] [Related]
3. Schizophrenia.
Lawrie S; McIntosh A; Nadeem Z
Clin Evid; 2005 Dec; (14):1306-30. PubMed ID: 16620456
[No Abstract] [Full Text] [Related]
4. [Current pharmacotherapy of schizophrenia].
Bitter I
Orv Hetil; 2004 Jan; 145(3):105-9. PubMed ID: 15027331
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluation.
Volavka J; Nolan KA; Kline L; Czobor P; Citrome L; Sheitman B; Lindenmayer JP; McEvoy J; Lieberman JA
Schizophr Res; 2005 Jul; 76(1):127-9. PubMed ID: 15927808
[No Abstract] [Full Text] [Related]
6. [Late schizophrenia].
Morishita S
Ryoikibetsu Shokogun Shirizu; 2003; (38):80-3. PubMed ID: 12876935
[No Abstract] [Full Text] [Related]
7. Acute respiratory distress due to antipsychotic drugs.
Yagmur F; Ulusoy HB; Buyukoglan H; Kaya MG
Pharmacopsychiatry; 2010 May; 43(3):118-9. PubMed ID: 20446229
[No Abstract] [Full Text] [Related]
8. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia.
Kapur S; Remington G
Annu Rev Med; 2001; 52():503-17. PubMed ID: 11160792
[TBL] [Abstract][Full Text] [Related]
9. Comparative effectiveness of antipsychotic drugs.
Gupta S
Am J Psychiatry; 2003 Mar; 160(3):591; author reply 592-3. PubMed ID: 12611855
[No Abstract] [Full Text] [Related]
10. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
[TBL] [Abstract][Full Text] [Related]
11. Amisulpride augmentation of clozapine in refractory schizophrenia.
Chiu HW; Ku YC; Li TC; Huang HT
J Neuropsychiatry Clin Neurosci; 2011; 23(3):E15. PubMed ID: 21948906
[No Abstract] [Full Text] [Related]
12. Amisulpride: a review of its efficacy in schizophrenia.
Möller HJ
Acta Psychiatr Scand Suppl; 2000; 400():17-22. PubMed ID: 10823307
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial.
Kahn RS; Fleischhacker WW; Boter H; Davidson M; Vergouwe Y; Keet IP; Gheorghe MD; Rybakowski JK; Galderisi S; Libiger J; Hummer M; Dollfus S; López-Ibor JJ; Hranov LG; Gaebel W; Peuskens J; Lindefors N; Riecher-Rössler A; Grobbee DE;
Lancet; 2008 Mar; 371(9618):1085-97. PubMed ID: 18374841
[TBL] [Abstract][Full Text] [Related]
14. Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.
Citrome L; Volavka J; Czobor P; Sheitman B; Lindenmayer JP; McEvoy J; Cooper TB; Chakos M; Lieberman JA
Psychiatr Serv; 2001 Nov; 52(11):1510-4. PubMed ID: 11684748
[TBL] [Abstract][Full Text] [Related]
15. Tardive dystonia induced by switch of atypical antipsychotics.
Chen CC; Chen YY; Hung GC
Pharmacopsychiatry; 2010 Jul; 43(5):200-1. PubMed ID: 20486043
[No Abstract] [Full Text] [Related]
16. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder.
Bilder RM; Goldman RS; Volavka J; Czobor P; Hoptman M; Sheitman B; Lindenmayer JP; Citrome L; McEvoy J; Kunz M; Chakos M; Cooper TB; Horowitz TL; Lieberman JA
Am J Psychiatry; 2002 Jun; 159(6):1018-28. PubMed ID: 12042192
[TBL] [Abstract][Full Text] [Related]
17. [Comparative studies of the effects of perazine, fluphenazine, trifluoperazine, chlorpromazine and haloperidol on primary and deficit symptoms of paranoid schizophrenia].
Termińska K; Mrowiec W
Psychiatr Pol; 1989; 23(1):24-30. PubMed ID: 2573098
[TBL] [Abstract][Full Text] [Related]
18. Switching to amisulpride due to hepatic complications.
Yagdiran O; Haasen C; Nika E; Krausz M; Naber D
Eur Psychiatry; 2002 May; 17(3):170-1. PubMed ID: 12052579
[No Abstract] [Full Text] [Related]
19. [The features of atypical neuroleptic amisulpride action].
Grigor'eva EA; Ritskov AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(6):59-64. PubMed ID: 15285638
[No Abstract] [Full Text] [Related]
20. Augmentation of clozapine with amisulpride: a promising therapeutic approach to refractory schizophrenic symptoms.
Kämpf P; Agelink MW; Naber D
Pharmacopsychiatry; 2005 Jan; 38(1):39-40. PubMed ID: 15706467
[No Abstract] [Full Text] [Related]
[Next] [New Search]